1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
GLOBAL PULMONARY DRUG DELIVERY MARKET FORECAST 2019-2028

GLOBAL PULMONARY DRUG DELIVERY MARKET FORECAST 2019-2028

  • August 2020
  • 248 pages
  • ID: 5953909
  • Format: PDF
  • Inkwood Research

Summary

Table of Contents

KEY FINDINGS
The global pulmonary drug delivery market is anticipated to register a CAGR of 5.06%, during the forecast years of 2019 to 2028. The key drivers, such as advancements in technology, the surging prevalence of respiratory diseases, and the rising geriatric population, are attributed to market growth.

MARKET INSIGHTS
With its recent introduction into the pharmaceutical field, pulmonary drug delivery systems are used to treat both local as well as systemic types of lung diseases.They are characterized by their ability to directly deliver medication to the designated location in the body or other distant sites through the bloodstream.

Moreover, different forms of drug delivery systems, including inhalers and nebulizers, were introduced as alternative treatments for diverse lung conditions.
Technology plays a crucial role in daily lives, and is consistently evolving.As a result, the rising demand for innovative products, incorporated with changing lifestyles, the need for convenience, and better facilities, leads to technological developments.

Similarly, the market for pulmonary drug delivery is fuelled by rising advancements in technology, and is projected to generate potential growth opportunities. The limitations of conventional treatments, such as low efficacy and delayed onset of action, are also predicted to encourage the development of innovative and superior targeted drug delivery systems.

REGIONAL INSIGHTS
The global pulmonary drug delivery market growth is geographically analyzed through the Asia Pacific, Europe, North America, and the rest of the world.The Asia Pacific is projected to be the fastest-growing region, owing to the high incidence of chronic obstructive pulmonary disease (COPD), indicating significant socioeconomic problems.

The rising number of patients with allergic rhinitis and asthma also contributes to the region’s market growth.

COMPETITIVE INSIGHTS
The market is competitive, with major players engaged in constant product developments, in addition to partnership agreements to ease market penetration.Moreover, the growing number of dealers and distributors is predicted to intensify the industry rivalry, in the upcoming years.

Leading companies operating in the market include, Boehringer Ingelheim GmbH, 3M Company, GlaxoSmithKline PLC, Koninklijke Philips NV, AstraZeneca PLC, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. 3M COMPANY
2. ACTELION PHARMACEUTICALS LTD
3. AEROGEN
4. AGILENT TECHNOLOGIES INC
5. ASTRAZENECA PLC
6. BOEHRINGER INGELHEIM GMBH
7. CLEMENT CLARKE INTERNATIONAL
8. GF HEALTH PRODUCTS INC
9. GLAXOSMITHKLINE PLC
10. KONINKLIJKE PHILIPS NV
11. MERCK & CO INC
12. NOVARTIS AG
13. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
14. VECTURA GROUP PLC

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Novel Drug Delivery Systems (NDDS) Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • January 2021
  • 124 pages

The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel ...

  • World
  • Europe
  • Drug Delivery
  • Industry analysis
  • Cancer Incidence
  • Chronic Disease Prevalence

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on